Related Experiment Video
Updated: Mar 7, 2026

Immunohistochemical Staining of B7-H1 PD-L1 on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue
Published on: January 3, 2013
BATF Drives Cervical Cancer Progression and Immune Evasion by Regulating the STAT1-PD-L1 Axis
Jun Zhang1, Yang Zhang1, Jinwei Zhang1
1Department of Gynecology, The Affliated Wuxi People's Hospital of Nanjing Medical University, Wuxi Medical Center, Nanjing Medical University, Wuxi People's Hospital, Wuxi, Jiangsu 214023, China.
Background:
Cervical cancer progression is driven by immune evasion mechanisms, including PD-L1-mediated suppression of T cell activity. BATF, a transcription factor, has been linked to tumor immunity; cancer remains incompletely understood.
Objective:
This study investigates the BATF-STAT1-PD-L1 axis in tumor progression and immune regulation.
Methods:
BATF expression was analyzed in cervical cancer tissues and cell lines. Functional assays assessed the impact of BATF knockdown on proliferation, apoptosis, autophagy, and migration. STAT1 regulation was examined via chromatin immunoprecipitation and Western blot. PD-L1 expression was measured by flow cytometry. In vivo xenograft models were used to evaluate tumor growth and response to PD-L1 blockade.
Results:
BATF was upregulated in cervical cancer and promoted tumor growth, metastasis, and immune evasion. BATF knockdown suppressed proliferation, enhanced apoptosis and autophagy, and reduced migration. Mechanistically, BATF transcriptionally activated STAT1, which induced PD-L1 expression. BATF suppression enhanced CD8⁺ T cell infiltration and improved the efficacy of PD-L1 blockade in vivo.
Conclusion:
BATF promotes cervical cancer progression by modulating STAT1 and PD-L1. Targeting BATF may enhance anti-tumor immunity and improve immunotherapy outcomes.
Insights
The transcription factor BATF promotes cervical cancer growth and immune evasion by activating STAT1 and PD-L1. Targeting BATF may improve cancer immunotherapy outcomes.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Cervical cancer progression involves immune evasion, notably through PD-L1 suppressing T cell activity.
- The transcription factor BATF's role in tumor immunity is recognized but not fully understood in cancer.
Purpose of the Study:
- To investigate the BATF-STAT1-PD-L1 signaling axis in cervical cancer progression.
- To elucidate the role of BATF in regulating tumor immunity and progression.
Main Methods:
- Analysis of BATF expression in cervical cancer tissues and cell lines.
- Functional assays (proliferation, apoptosis, autophagy, migration) following BATF knockdown.
- Chromatin immunoprecipitation and Western blot to assess STAT1 regulation.
- Flow cytometry for PD-L1 expression and in vivo xenograft models for tumor growth and immunotherapy response.
Main Results:
- BATF was upregulated in cervical cancer, promoting tumor growth, metastasis, and immune evasion.
- BATF knockdown inhibited proliferation, enhanced apoptosis and autophagy, and reduced migration.
- BATF transcriptionally activated STAT1, leading to PD-L1 induction. BATF suppression increased CD8+ T cell infiltration and enhanced PD-L1 blockade efficacy.
Conclusions:
- BATF drives cervical cancer progression via STAT1 and PD-L1 modulation.
- Targeting BATF presents a potential strategy to enhance anti-tumor immunity and immunotherapy efficacy.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
Inhibition of Cdk Activity
Cancer Cell Migration through Invadopodia
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

